Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
17 June 2021Website:
http://ispecimen.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:56:23 GMTDividend
Analysts recommendations
Institutional Ownership
ISPC Latest News
iSpecimen Inc. (NASDAQ: ISPC) Q1 2024 Earnings Conference Call on May 7, 2024 at 8:30 AM ET with company representatives including Phil Carlson, Tracy Curley, and Leslie Hoyt. Conference call participants include Matt Hewitt from Craig Hallum Capital. The call is being recorded.
The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern
iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Carly Lejnieks - Vice President of Marketing. Conference Call Participants Matt Hewitt - Craig Hallum Operator Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call.
iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Eric Langlois - Chief Revenue Officer Evan Cox - Vice President of Product Management Conference Call Participants Operator Good day, everyone, and welcome to iSpecimen's Second Quarter 2023 Results Conference Call. At this time participants are in a listen-only mode.
iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benjamin Beilak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig Hallum Capital Group Operator Good morning, and welcome to iSpecimen First Quarter 2023 Earnings Conference Call [Operator Instructions]. Please note that this event is being recorded.
What type of business is iSpecimen?
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
What sector is iSpecimen in?
iSpecimen is in the Healthcare sector
What industry is iSpecimen in?
iSpecimen is in the Diagnostics & Research industry
What country is iSpecimen from?
iSpecimen is headquartered in United States
When did iSpecimen go public?
iSpecimen initial public offering (IPO) was on 17 June 2021
What is iSpecimen website?
https://ispecimen.com
Is iSpecimen in the S&P 500?
No, iSpecimen is not included in the S&P 500 index
Is iSpecimen in the NASDAQ 100?
No, iSpecimen is not included in the NASDAQ 100 index
Is iSpecimen in the Dow Jones?
No, iSpecimen is not included in the Dow Jones index
When does iSpecimen report earnings?
Next earnings report date is not announced yet